320 related articles for article (PubMed ID: 27222532)
21. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.
Canto MI; Goggins M; Hruban RH; Petersen GM; Giardiello FM; Yeo C; Fishman EK; Brune K; Axilbund J; Griffin C; Ali S; Richman J; Jagannath S; Kantsevoy SV; Kalloo AN
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):766-81; quiz 665. PubMed ID: 16682259
[TBL] [Abstract][Full Text] [Related]
22. Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS.
Kobayashi G; Fujita N; Noda Y; Ito K; Horaguchi J; Takasawa O; Akaishi S; Tsuchiya T; Kobari M
J Gastroenterol; 2005 Jul; 40(7):744-51. PubMed ID: 16082592
[TBL] [Abstract][Full Text] [Related]
23. Successful Pancreatic Cancer Screening Among Individuals at Elevated Risk Using Endoscopic Ultrasound and Magnetic Resonance Imaging: A Community Hospital Experience.
Raff JP; Cook B; Jafri FN; Boxer N; Maldonado J; Hopkins U; Roayaie S; Noyer C
Pancreas; 2022 Nov-Dec 01; 51(10):1345-1351. PubMed ID: 37099777
[TBL] [Abstract][Full Text] [Related]
24. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.
Poley JW; Kluijt I; Gouma DJ; Harinck F; Wagner A; Aalfs C; van Eijck CH; Cats A; Kuipers EJ; Nio Y; Fockens P; Bruno MJ
Am J Gastroenterol; 2009 Sep; 104(9):2175-81. PubMed ID: 19491823
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Yield From Screening Asymptomatic Individuals at High Risk for Pancreatic Cancer: A Meta-analysis of Cohort Studies.
Corral JE; Mareth KF; Riegert-Johnson DL; Das A; Wallace MB
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):41-53. PubMed ID: 29775792
[TBL] [Abstract][Full Text] [Related]
26. High Growth Rate of Pancreatic Ductal Adenocarcinoma in
Ibrahim IS; Wasser MN; Wu Y; Inderson A; de Vos Tot Nederveen Cappel WH; Morreau H; Hes FJ; Veenendaal RA; Putter H; Feshtali S; van Mil AM; Gruis NA; Tollenaar RA; Bergman W; Bonsing BA; Vasen HFA
Cancer Prev Res (Phila); 2018 Sep; 11(9):551-556. PubMed ID: 29991580
[No Abstract] [Full Text] [Related]
27. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
[TBL] [Abstract][Full Text] [Related]
28. New strategies for the early detection of pancreatic cancer.
Petrone MC; Arcidiacono PG
Expert Rev Gastroenterol Hepatol; 2016; 10(2):157-9. PubMed ID: 26582179
[TBL] [Abstract][Full Text] [Related]
29. Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.
Del Chiaro M; Verbeke CS; Kartalis N; Pozzi Mucelli R; Gustafsson P; Hansson J; Haas SL; Segersvärd R; Andren-Sandberg Å; Löhr JM
JAMA Surg; 2015 Jun; 150(6):512-8. PubMed ID: 25853369
[TBL] [Abstract][Full Text] [Related]
30. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.
Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ
J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680
[TBL] [Abstract][Full Text] [Related]
31. Promising outcomes of screening for pancreatic cancer by genetic testing and endoscopic ultrasound.
Sud A; Wham D; Catalano M; Guda NM
Pancreas; 2014 Apr; 43(3):458-61. PubMed ID: 24622079
[TBL] [Abstract][Full Text] [Related]
32. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic Cancer Screening for At-Risk Individuals (Pancreas Scan Study): Yield, Harms, and Outcomes From a Prospective Multicenter Study.
Shah I; Silva-Santisteban A; Germansky KA; Trindade A; Raphael KL; Kushnir V; Pawa R; Mishra G; Anastasiou J; Inamdar S; Tharian B; Bilal M; Sawhney MS
Am J Gastroenterol; 2023 Sep; 118(9):1664-1670. PubMed ID: 37141538
[TBL] [Abstract][Full Text] [Related]
34. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
[TBL] [Abstract][Full Text] [Related]
35. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
36. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
[TBL] [Abstract][Full Text] [Related]
37. Role of endoscopic retrograde pancreatography for early detection of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas.
Ohtsuka T; Ideno N; Aso T; Nagayoshi Y; Kono H; Mori Y; Takahata S; Oda Y; Aishima S; Igarashi H; Ito T; Ishigami K; Nakamura M; Mizumoto K; Tanaka M
J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):356-61. PubMed ID: 22878836
[TBL] [Abstract][Full Text] [Related]
38. Linear-array EUS improves detection of pancreatic lesions in high-risk individuals: a randomized tandem study.
Shin EJ; Topazian M; Goggins MG; Syngal S; Saltzman JR; Lee JH; Farrell JJ; Canto MI
Gastrointest Endosc; 2015 Nov; 82(5):812-8. PubMed ID: 25930097
[TBL] [Abstract][Full Text] [Related]
39. Concordance of EUS and MRI/MRCP findings among high-risk individuals undergoing pancreatic cancer screening.
Siegel A; Friedman M; Feldman D; Krishnan K; Casey B; Pisuchpen N; Kambadakone A; Chung DC
Pancreatology; 2022 Nov; 22(7):951-958. PubMed ID: 35995658
[TBL] [Abstract][Full Text] [Related]
40. Incidentally discovered pancreatic intraepithelial neoplasia: what is its clinical significance?
Konstantinidis IT; Vinuela EF; Tang LH; Klimstra DS; D'Angelica MI; Dematteo RP; Kingham TP; Fong Y; Jarnagin WR; Allen PJ
Ann Surg Oncol; 2013 Oct; 20(11):3643-7. PubMed ID: 23748606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
